148 related articles for article (PubMed ID: 37937777)
1. Trial of Botulinum Toxin for Isolated or Essential Head Tremor.
Marques A; Pereira B; Simonetta-Moreau M; Castelnovo G; De Verdal M; Fluchère F; Laurencin C; Degos B; Tir M; Kreisler A; Blanchet-Fourcade G; Guehl D; Colin O; Poujois A; Sangla S; Tatu L; Derost P; Gayraud D; Tranchant C; Amarantini D; Devos D; Rascol O; Corvol JC; Durif F; Rieu I;
N Engl J Med; 2023 Nov; 389(19):1753-1765. PubMed ID: 37937777
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Botulinum Neurotoxin Injection for Dystonic Hand Tremor: A Randomized Clinical Trial.
Rajan R; Srivastava AK; Anandapadmanabhan R; Saini A; Upadhyay A; Gupta A; Vishnu VY; Pandit AK; Vibha D; Singh MB; Bhatia R; Goyal V; Dwivedi SN; Srivastava P; Prasad K
JAMA Neurol; 2021 Mar; 78(3):302-311. PubMed ID: 33346814
[TBL] [Abstract][Full Text] [Related]
3. Tolerability and Efficacy of Customized IncobotulinumtoxinA Injections for Essential Tremor: A Randomized, Double-Blind, Placebo-Controlled Study.
Jog M; Lee J; Scheschonka A; Chen R; Ismail F; Boulias C; Hobson D; King D; Althaus M; Simon O; Dersch H; Frucht S; Simpson DM
Toxins (Basel); 2020 Dec; 12(12):. PubMed ID: 33419261
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin type B for cervical dystonia.
Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
[TBL] [Abstract][Full Text] [Related]
5. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor.
Brin MF; Lyons KE; Doucette J; Adler CH; Caviness JN; Comella CL; Dubinsky RM; Friedman JH; Manyam BV; Matsumoto JY; Pullman SL; Rajput AH; Sethi KD; Tanner C; Koller WC
Neurology; 2001 Jun; 56(11):1523-8. PubMed ID: 11402109
[TBL] [Abstract][Full Text] [Related]
6. Novel Botulinum Toxin Injection Protocols for Parkinson Tremor and Essential Tremor - the Yale Technique and Sensor-Based Kinematics Procedure for Safe and Effective Treatment.
Mittal SO; Jog M; Lee J; Jabbari B
Tremor Other Hyperkinet Mov (N Y); 2020 Dec; 10():61. PubMed ID: 33442486
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin type A therapy for cervical dystonia.
Castelão M; Marques RE; Duarte GS; Rodrigues FB; Ferreira J; Sampaio C; Moore AP; Costa J
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD003633. PubMed ID: 29230798
[TBL] [Abstract][Full Text] [Related]
8. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke.
Brashear A; Gordon MF; Elovic E; Kassicieh VD; Marciniak C; Do M; Lee CH; Jenkins S; Turkel C;
N Engl J Med; 2002 Aug; 347(6):395-400. PubMed ID: 12167681
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of repeated injections of botulinum toxin A in peripheral neuropathic pain (BOTNEP): a randomised, double-blind, placebo-controlled trial.
Attal N; de Andrade DC; Adam F; Ranoux D; Teixeira MJ; Galhardoni R; Raicher I; Üçeyler N; Sommer C; Bouhassira D
Lancet Neurol; 2016 May; 15(6):555-65. PubMed ID: 26947719
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of Intralesional Botulinum Toxin A for Treatment of Painful Cutaneous Leiomyomas: A Randomized Clinical Trial.
Naik HB; Steinberg SM; Middelton LA; Hewitt SM; Zuo RC; Linehan WM; Kong HH; Cowen EW
JAMA Dermatol; 2015 Oct; 151(10):1096-102. PubMed ID: 26244563
[TBL] [Abstract][Full Text] [Related]
11. Botulinum toxins for the prevention of migraine in adults.
Herd CP; Tomlinson CL; Rick C; Scotton WJ; Edwards J; Ives N; Clarke CE; Sinclair A
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD011616. PubMed ID: 29939406
[TBL] [Abstract][Full Text] [Related]
12. Treatment of major depressive disorder using botulinum toxin A: a 24-week randomized, double-blind, placebo-controlled study.
Magid M; Reichenberg JS; Poth PE; Robertson HT; LaViolette AK; Kruger TH; Wollmer MA
J Clin Psychiatry; 2014 Aug; 75(8):837-44. PubMed ID: 24910934
[TBL] [Abstract][Full Text] [Related]
13. Long-term tremor therapy for Parkinson and essential tremor with sensor-guided botulinum toxin type A injections.
Samotus O; Lee J; Jog M
PLoS One; 2017; 12(6):e0178670. PubMed ID: 28586370
[TBL] [Abstract][Full Text] [Related]
14. Use of anatomic measurement to guide injection of botulinum toxin for the management of chronic lateral epicondylitis: a randomized controlled trial.
Espandar R; Heidari P; Rasouli MR; Saadat S; Farzan M; Rostami M; Yazdanian S; Mortazavi SM
CMAJ; 2010 May; 182(8):768-73. PubMed ID: 20421357
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders.
Blumenfeld A
Headache; 2003 Sep; 43(8):853-60. PubMed ID: 12940806
[TBL] [Abstract][Full Text] [Related]
16. Does botulinum toxin injection site determine outcome in post-stroke plantarflexion spasticity? Comparison study of two injection sites in the gastrocnemius muscle: a randomized double-blind controlled trial.
Im S; Park JH; Son SK; Shin JE; Cho SH; Park GY
Clin Rehabil; 2014 Jun; 28(6):604-13. PubMed ID: 24452704
[TBL] [Abstract][Full Text] [Related]
17. The treatment of essential voice tremor with botulinum toxin A: a longitudinal case report.
Warrick P; Dromey C; Irish J; Durkin L
J Voice; 2000 Sep; 14(3):410-21. PubMed ID: 11021508
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, randomized, controlled study of botulinum toxin type A in MS-related tremor.
Van Der Walt A; Sung S; Spelman T; Marriott M; Kolbe S; Mitchell P; Evans A; Butzkueven H
Neurology; 2012 Jul; 79(1):92-9. PubMed ID: 22753445
[TBL] [Abstract][Full Text] [Related]
19. BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.
Shaw L; Rodgers H; Price C; van Wijck F; Shackley P; Steen N; Barnes M; Ford G; Graham L;
Health Technol Assess; 2010 May; 14(26):1-113, iii-iv. PubMed ID: 20515600
[TBL] [Abstract][Full Text] [Related]
20. A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor.
Jankovic J; Schwartz K; Clemence W; Aswad A; Mordaunt J
Mov Disord; 1996 May; 11(3):250-6. PubMed ID: 8723140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
